{"id":"https://openalex.org/W3012236331","doi":"https://doi.org/10.1089/mdr.2019.0497","title":"Cultural Drivers of Antibiotic Consumption in High-Income Countries: A Global Ecological Analysis","display_name":"Cultural Drivers of Antibiotic Consumption in High-Income Countries: A Global Ecological Analysis","alternate_titles":[],"publication_year":2020,"publication_date":"2020-03-17","ids":{"openalex":"https://openalex.org/W3012236331","doi":"https://doi.org/10.1089/mdr.2019.0497","mag":"3012236331","pmid":"https://pubmed.ncbi.nlm.nih.gov/32182187"},"language":"en","primary_location":{"id":"doi:10.1089/mdr.2019.0497","doi":"https://doi.org/10.1089/mdr.2019.0497","is_oa":false,"landing_page_url":"https://doi.org/10.1089/mdr.2019.0497","pdf_url":null,"source":{"id":"https://openalex.org/S178647319","display_name":"Microbial Drug Resistance","issn_l":"1076-6294","issn":["1076-6294","1931-8448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Microbial Drug Resistance","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3012236331"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058895835","display_name":"Chris Richard Kenyon","orcid":"https://orcid.org/0000-0002-2557-8998","observed_orcids":["https://orcid.org/0000-0002-2557-8998"]},"institutions":[{"id":"https://openalex.org/I157614274","display_name":"University of Cape Town","ror":"https://ror.org/03p74gp79","country_code":"ZA","type":"education","lineage":["https://openalex.org/I157614274"]},{"id":"https://openalex.org/I78281549","display_name":"Instituut voor Tropische Geneeskunde","ror":"https://ror.org/03xq4x896","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I78281549"]}],"countries":["BE","ZA"],"is_corresponding":true,"raw_author_name":"Chris Kenyon","raw_affiliation_strings":["Division of Infectious Diseases and HIV Medicine, University of Cape Town, Observatory, South Africa","HIV/STI Unit, Institute of Tropical Medicine, Antwerp, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases and HIV Medicine, University of Cape Town, Observatory, South Africa","institution_ids":["https://openalex.org/I157614274"]},{"raw_affiliation_string":"HIV/STI Unit, Institute of Tropical Medicine, Antwerp, Belgium","institution_ids":["https://openalex.org/I78281549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034771291","display_name":"Sheeba Santhini Manoharan-Basil","orcid":"https://orcid.org/0000-0001-8421-5137","observed_orcids":["https://orcid.org/0000-0001-8421-5137"]},"institutions":[{"id":"https://openalex.org/I78281549","display_name":"Instituut voor Tropische Geneeskunde","ror":"https://ror.org/03xq4x896","country_code":"BE","type":"nonprofit","lineage":["https://openalex.org/I78281549"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Sheeba S. Manoharan-Basil","raw_affiliation_strings":["HIV/STI Unit, Institute of Tropical Medicine, Antwerp, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HIV/STI Unit, Institute of Tropical Medicine, Antwerp, Belgium","institution_ids":["https://openalex.org/I78281549"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5058895835"],"corresponding_institution_ids":["https://openalex.org/I157614274","https://openalex.org/I78281549"],"apc_list":null,"apc_paid":null,"fwci":0.568,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.81470771,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":98},"biblio":{"volume":"26","issue":"9","first_page":"1063","last_page":"1070"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10897","display_name":"Antibiotic Use and Resistance","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13555","display_name":"Healthcare cost, quality, practices","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11454","display_name":"Cultural Differences and Values","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3207","display_name":"Social Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibiotic-use","display_name":"antibiotic use","score":0.9950000047683716},{"id":"https://openalex.org/keywords/cultural-factors","display_name":"cultural factors","score":0.6380000114440918},{"id":"https://openalex.org/keywords/uncertainty-avoidance","display_name":"uncertainty avoidance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/corruption","display_name":"corruption","score":0.7820000052452087},{"id":"https://openalex.org/keywords/governance","display_name":"governance","score":0.5759999752044678},{"id":"https://openalex.org/keywords/cephalosporins","display_name":"cephalosporins","score":0.8830000162124634},{"id":"https://openalex.org/keywords/fluoroquinolones","display_name":"fluoroquinolones","score":0.9900000095367432},{"id":"https://openalex.org/keywords/macrolides","display_name":"macrolides","score":1.0},{"id":"https://openalex.org/keywords/antibiotic-stewardship","display_name":"antibiotic stewardship","score":0.9229999780654907},{"id":"https://openalex.org/keywords/high-income-countries","display_name":"high-income countries","score":0.8880000114440918}],"concepts":[{"id":"https://openalex.org/C30772137","wikidata":"https://www.wikidata.org/wiki/Q5164762","display_name":"Consumption (sociology)","level":2,"score":0.6300780773162842},{"id":"https://openalex.org/C39389867","wikidata":"https://www.wikidata.org/wiki/Q380767","display_name":"Corporate governance","level":2,"score":0.571734607219696},{"id":"https://openalex.org/C127598652","wikidata":"https://www.wikidata.org/wiki/Q558635","display_name":"Per capita","level":3,"score":0.5659452080726624},{"id":"https://openalex.org/C114350782","wikidata":"https://www.wikidata.org/wiki/Q12638","display_name":"Gross domestic product","level":2,"score":0.5475637912750244},{"id":"https://openalex.org/C2780027415","wikidata":"https://www.wikidata.org/wiki/Q524648","display_name":"Language change","level":2,"score":0.4506148099899292},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44217821955680847},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.3769995868206024},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.3315102159976959},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.32926303148269653},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.2764064371585846},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.27570658922195435},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.14957115054130554},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.09158143401145935},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.07630655169487},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.0},{"id":"https://openalex.org/C142362112","wikidata":"https://www.wikidata.org/wiki/Q735","display_name":"Art","level":0,"score":0.0},{"id":"https://openalex.org/C124952713","wikidata":"https://www.wikidata.org/wiki/Q8242","display_name":"Literature","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000569","descriptor_name":"Americas","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001362","descriptor_name":"Avoidance Learning","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002511","descriptor_name":"Cephalosporins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003431","descriptor_name":"Cross-Cultural Comparison","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D004363","descriptor_name":"Drug Utilization","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D005060","descriptor_name":"Europe","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007182","descriptor_name":"Income","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007722","descriptor_name":"Health Knowledge, Attitudes, Practice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016014","descriptor_name":"Linear Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018942","descriptor_name":"Macrolides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019049","descriptor_name":"Developed Countries","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D024841","descriptor_name":"Fluoroquinolones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D035501","descriptor_name":"Uncertainty","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059066","descriptor_name":"Gross Domestic Product","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/mdr.2019.0497","doi":"https://doi.org/10.1089/mdr.2019.0497","is_oa":false,"landing_page_url":"https://doi.org/10.1089/mdr.2019.0497","pdf_url":null,"source":{"id":"https://openalex.org/S178647319","display_name":"Microbial Drug Resistance","issn_l":"1076-6294","issn":["1076-6294","1931-8448"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Microbial Drug Resistance","raw_type":"journal-article"},{"id":"pmid:32182187","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32182187","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Microbial drug resistance (Larchmont, N.Y.)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1530269410","https://openalex.org/W1847628049","https://openalex.org/W2021077669","https://openalex.org/W2032605132","https://openalex.org/W2056830352","https://openalex.org/W2077411963","https://openalex.org/W2090528639","https://openalex.org/W2097869529","https://openalex.org/W2100353213","https://openalex.org/W2102933821","https://openalex.org/W2112801526","https://openalex.org/W2114569183","https://openalex.org/W2118175562","https://openalex.org/W2118514877","https://openalex.org/W2134262748","https://openalex.org/W2136960553","https://openalex.org/W2138008655","https://openalex.org/W2139650157","https://openalex.org/W2146875579","https://openalex.org/W2147565768","https://openalex.org/W2570245210","https://openalex.org/W2587986375","https://openalex.org/W2791781902","https://openalex.org/W2803937282","https://openalex.org/W2889006122","https://openalex.org/W2899736836","https://openalex.org/W2939022672","https://openalex.org/W2955031241","https://openalex.org/W2957995128","https://openalex.org/W3007780591"],"related_works":["https://openalex.org/W2134262748","https://openalex.org/W2957995128","https://openalex.org/W2587986375","https://openalex.org/W7128308894","https://openalex.org/W3035782768","https://openalex.org/W2336386073","https://openalex.org/W2112801526","https://openalex.org/W2889006122","https://openalex.org/W3091812575","https://openalex.org/W1931779216"],"abstract_inverted_index":{"Background:":[0],"Previous":[1],"studies":[2,26,37,60],"evaluating":[3],"the":[4,10,14,45,87,108,120,141,146,152,159,190,196,201,239],"cultural":[5,41],"and":[6,51,66,100,111,116,128,136,180,186,216,244],"structural":[7],"factors":[8,42],"underpinning":[9],"large":[11],"variations":[12],"in":[13,18],"consumption":[15,84,102],"of":[16,47,114,130,134,177,192,198,242],"antibiotics":[17],"high-income":[19,76],"countries":[20,77,171,215,220],"have":[21,27,38,61],"reached":[22],"different":[23],"conclusions.":[24],"Some":[25],"found":[28],"that":[29,40,235],"corruption":[30],"plays":[31],"a":[32],"dominant":[33],"role,":[34],"whereas":[35],"other":[36],"concluded":[39],"such":[43],"as":[44,107,145],"degree":[46],"uncertainty":[48],"avoidance":[49],"(UA)":[50],"performance-orientation":[52],"versus":[53],"cooperation-orientation":[54],"(POCO)":[55],"are":[56,236],"more":[57],"important.":[58],"These":[59],"been":[62],"limited":[63,211],"to":[64,70,74,162,212,218,230,238],"Europe,":[65],"we,":[67],"therefore,":[68],"aimed":[69],"expand":[71],"this":[72],"analysis":[73],"all":[75],"with":[78,96,184,203],"available":[79,168],"data.":[80],"Methods:":[81],"Using":[82],"antibiotic":[83,232],"data":[85,166],"from":[86,119,140,172],"IQVIA":[88],"MIDAS":[89],"database,":[90],"linear":[91],"regression":[92],"models":[93],"were":[94,167],"constructed":[95],"country-level":[97,156],"cephalosporin,":[98],"fluoroquinolone,":[99],"macrolide":[101,199],"(defined":[103],"daily":[104],"doses/1,000":[105],"population/year)":[106],"outcome":[109],"variables":[110],"country-specific":[112],"scores":[113],"UA":[115,204,243],"POCO":[117,185],"(obtained":[118],"Hofstede":[121,153],"Index),":[122],"gross":[123],"domestic":[124],"product/capita,":[125],"world":[126,174],"region":[127],"markers":[129,191],"effective":[131,193],"governance":[132],"(Control":[133],"Corruption":[135],"Regulatory":[137],"Quality":[138],"extracted":[139],"World":[142],"Bank":[143],"data)":[144],"explanatory":[147],"variables.":[148],"All":[149],"data,":[150],"excluding":[151],"Indices,":[154],"used":[155],"averages":[157],"for":[158,169],"years":[160],"2013":[161],"2015.":[163],"Results:":[164],"Complete":[165],"37":[170],"4":[173],"regions.":[175],"Consumption":[176],"cephalosporins,":[178],"macrolides,":[179],"fluoroquinolones":[181],"was":[182],"associated":[183],"UA,":[187],"but":[188],"not":[189],"governance.":[194],"In":[195],"case":[197],"consumption,":[200],"association":[202],"narrowly":[205],"missed":[206],"statistical":[207],"significance.":[208],"Repeat":[209],"analyses":[210],"first":[213],"European":[214],"second":[217],"non-European":[219],"revealed":[221],"similar":[222],"findings.":[223],"Conclusions:":[224],"More":[225],"thought":[226],"should":[227],"be":[228],"given":[229],"construct":[231],"stewardship":[233],"campaigns":[234],"tailored":[237],"local":[240],"extent":[241],"POCO.":[245]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3012236331","counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":4}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2020-03-23T00:00:00"}
